79 filings
Page 2 of 4
8-K
48mzjhx4b738g5h0x
8 Mar 23
Entry into a Material Definitive Agreement
8:00am
8-K
dyhow not889ekkh0
10 Feb 23
Anebulo Pharmaceuticals Reports Second Quarter Fiscal Year 2023 Financial Results and Recent Updates
8:15am
8-K
uu4bkxyq6
9 Jan 23
Results of Operations and Financial Condition
8:00am
8-K
mdsqdnwg5 at
10 Nov 22
Anebulo Pharmaceuticals Reports First Quarter Fiscal Year 2023 Financial Results and Recent Updates
8:15am
EFFECT
nj5vc3pqi9h 52h
10 Nov 22
Notice of effectiveness
12:00am
CORRESP
xougic37y icsyk
8 Nov 22
Correspondence with SEC
12:00am
UPLOAD
avjrtll
8 Nov 22
Letter from SEC
12:00am
8-K
bcul2oi3
28 Oct 22
Submission of Matters to a Vote of Security Holders
4:05pm
DEFR14A
z12bzcac5 xu4xvw07
25 Oct 22
Revised proxy
5:27pm
8-K
xontnjyw x4yeg
13 Oct 22
Amendments to Articles of Incorporation or Bylaws
4:05pm
D
og2wtc z1ayoueeh2gqt
7 Oct 22
$16.19 mm in equity / options / securities to be acquired, sold $6.65 mm, 5 investors
5:32pm
8-K
2hwc57l70adapt
29 Sep 22
Anebulo Pharmaceuticals Announces $6.6 million Private Placement Financing
4:05pm
8-K
zcvz4etmxfao
26 Sep 22
Regulation FD Disclosure
8:00am
8-K
g55qqrewyx8mr98
9 Sep 22
Anebulo Pharmaceuticals Reports Fourth Quarter and Fiscal Year 2022
8:00am
8-K
j7svkf40l1kvpmev6j
5 Jul 22
Regulation FD Disclosure
8:17am